Zai Lab
Founded Year
2014Stage
IPO | IPOTotal Raised
$166MDate of IPO
9/20/2017Market Cap
2.71BStock Price
2.75About Zai Lab
Zai Lab (NASDAQ: ZLAB) operates as a biopharmaceutical company. It develops and commercializes a pipeline of antibody-based therapies and other protein-based therapeutics. It offers products and therapies that modulate the immune system and target tumors. The company was founded in 2014 and is based in Shanghai, China.
Loading...
Loading...
Zai Lab Patents
Zai Lab has filed 1 patent.
The 3 most popular patent topics include:
- antineoplastic drugs
- coupling reactions
- experimental cancer drugs
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/12/2018 | 2/23/2021 | Coupling reactions, Trifluoromethyl compounds, Antineoplastic drugs, Experimental cancer drugs, Substitution reactions | Grant |
Application Date | 10/12/2018 |
|---|---|
Grant Date | 2/23/2021 |
Title | |
Related Topics | Coupling reactions, Trifluoromethyl compounds, Antineoplastic drugs, Experimental cancer drugs, Substitution reactions |
Status | Grant |
Latest Zai Lab News
Nov 17, 2023
Zai Lab (NASDAQ: ZLAB ) President and Chief Operating Officer Josh Smiley purchased 5,000 shares in the company for a transaction value of $134,650 on Nov. 16, the company disclosed in a filing. Zai Lab shares were trading +4.02% higher at $27.46.
Zai Lab Frequently Asked Questions (FAQ)
When was Zai Lab founded?
Zai Lab was founded in 2014.
Where is Zai Lab's headquarters?
Zai Lab's headquarters is located at Building 1, 4/F Jinchuang Plaza, Shanghai.
What is Zai Lab's latest funding round?
Zai Lab's latest funding round is IPO.
How much did Zai Lab raise?
Zai Lab raised a total of $166M.
Who are the investors of Zai Lab?
Investors of Zai Lab include Qiming Venture Partners, OrbiMed Advisors, Cormorant Asset Management, Vivo Capital, Rock Springs Capital and 7 more.
Loading...
Loading...